TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/17/24 19:14 | 1/14/24 | MGTX | Meiragtx Holdings Plc | E9 | Health | BioPrd | Biological Products, (No Diag | Naylor Stuart | NY | O | CHIEF DE | M.d | 0 | 0.00 | 0 | 24 | 4 | 564 | D | ||||||||||||||
1/9/24 17:25 | 1/7/24 | MGTX | Meiragtx Holdings Plc | E9 | Health | BioPrd | Biological Products, (No Diag | Naylor Stuart | NY | O | CHIEF DE | M.dm | 0 | 0.00 | 0 | 115 | 26 | 552 | D | ||||||||||||||
1/18/23 17:01 | 1/14/23 | MGTX | Meiragtx Holdings Plc | E9 | Health | BioPrd | Biological Products, (No Diag | Naylor Stuart | NY | O | CHIEF DE | M.d | 0 | 0.00 | 0 | 48 | 11 | 491 | D | ||||||||||||||
1/10/23 17:27 | 1/8/23 | MGTX | Meiragtx Holdings Plc | E9 | Health | BioPrd | Biological Products, (No Diag | Naylor Stuart | NY | O | CHIEF DE | M.d | 0 | 0.00 | 0 | 40 | 9 | 466 | D | ||||||||||||||
1/11/22 17:25 | 1/8/22 | MGTX | Meiragtx Holdings Plc | E9 | Health | BioPrd | Biological Products, (No Diag | Naylor Stuart | NY | O | Chief De | M.d | 0 | 0.00 | 0 | 80 | 22 | 444 | D | ||||||||||||||
10/20/21 17:16 | 10/18/21 | MGTX | Meiragtx Holdings Plc | E9 | Health | BioPrd | Biological Products, (No Diag | Naylor Stuart | NY | O | Chief De | S | -215 | 17.95 | 0 | -12 | -3 | 402 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |